Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast

Oncogene

Volumn 29, Issue 12, 2010, Pages 1732-1740

  Bauer, M ^a,c   Su, G ^a   Casper, C ^b,d   He, R ^a   Rehrauer, W ^a   Friedl, A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Fibroblasts; Invasion; Tumor stroma

Indexed keywords

GENE PRODUCT; KRUPPEL LIKE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BAYES THEOREM; BREAST CARCINOMA; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PARACRINE SIGNALING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION REGULATION; UPREGULATION; VALIDATION PROCESS;

BAYES THEOREM; BREAST; BREAST NEOPLASMS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PREGNANCY; PROBABILITY; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSCRIPTION, GENETIC;

EID: 77950099096     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.463     Document Type: Article

References (45)

1. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H et al. (2004). Molecular characterization of the tumor micro-environment in breast cancer. Cancer Cell 6: 17-32.
2. Briand P, Nielsen KV, Madsen MW, Petersen OW. (1996). Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res 56: 2039-2044.
3. Campbell IG, Qiu W, Polyak K, Haviv I. (2008). Breast-cancer stromal cells with TP53 mutations. N Engl J Med 358: 1634-1635; author reply 1636.
4. Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O et al. (2008). Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 114: 47-62.
5. Chang CF, Westbrook R, Ma J, Cao D. (2007). Transforming growth factor-beta signaling in breast cancer. Front Biosci 12: 4393-4401.
6. de Jong JS, van Diest PJ, van der Valk P, Baak JP. (1998). Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: an inventory in search of autocrine and paracrine loops. J Pathol 184: 44-52.
7. Duque JL, Adam RM, Mullen JS, Lin J, Richie JP, Freeman MR. (2001). Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro. J Urol 165: 284-288.
8. Erickson AC, Barcellos-Hoff MH. (2003). The not-so innocent bystander: the microenvironment as a therapeutic target in cancer. Expert Opin Ther Targets 7: 71-88.
9. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V et al. (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15: 68-74.
10. Fiegl H, Millinger S, Goebel G, Muller-Holzner E, Marth C, Laird PW et al. (2006). Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res 66: 29-33.
11. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H et al. (2008). Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527.
12. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
13. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V et al. (2005). Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37: 899-905.
14. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE. (2002). The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 62: 5351-5357.
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
16. Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang L et al. (2004). Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res 64: 7610-7617.
17. Kalluri R, Zeisberg M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
18. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
19. Kendziorski CM, Newton MA, Lan H, Gould MN. (2003). On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles. Stat Med 22: 3899-3914.
20. Kim YC, Clark RJ, Ranheim EA, Alexander CM. (2008). Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effector. Cancer Res 68: 10145-10153.
21. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. (2002). Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32: 355-357.
22. Lewis MJ, Wiebe JP, Heathcote JG. (2004). Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4: 27.
23. Massague J. (2007). Sorting out breast-cancer gene signatures. N Engl J Med 356: 294-297.
24. Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A et al. (2008). Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther 7: 1212-1225.
25. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP et al. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339.
26. Mueller MM, Fusenig NE. (2004). Friends or foes\ bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
27. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW, De La Chapelle A et al. (2004). Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23: 7366-7377.
28. Narita K, Chien J, Mullany SA, Staub J, Qian X, Lingle WL et al. (2007). Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. J Biol Chem 282: 14413-14420.
29. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
30. Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL et al. (2007). Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357: 2543-2551.
31. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J et al. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95: 14717-14722.
32. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747-752.
33. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M et al. (2008). No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40: 650-655.
34. R-Development-Core-Team (2008). A language and environment for statistical computing. R Foundation for Statistical Computing. http://www.r-project.org.
35. Singer CF, Gschwantler-Kaulich D, Fink-Retter A, Haas C, Hudelist G, Czerwenka K et al. (2007). Differential gene expression profile in breast cancer-derived stromal fibroblasts. Breast Cancer Res Treat 110: 273-281.
36. Singer CF, Gschwantler-Kaulich D, Fink-Retter A, Haas C, Hudelist G, Czerwenka K et al. (2008). Differential gene expression profile in breast cancer-derived stromal fibroblasts. Breast Cancer Res Treat 110: 273-281.
37. Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, Hirtenlehner K et al. (2002). MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat 72: 69-77.
38. Storey JD, Tibshirani R. (2003). Statistical significance for genome-wide studies. Proc Natl Acad Sci USA 100: 9440-9445.
39. Sutmuller M, Bruijn JA, de Heer E. (1997). Collagen types VIII and X, two non-fibrillar, short-chain collagens. Structure homologies, functions and involvement in pathology. Histol Histopathol 12: 557-566.
40. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
41. Tang Y, Kesavan P, Nakada MT, Yan L. (2004). Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80.
42. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
43. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61: 8917-8923.
44. You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL et al. (2002). Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 157: 429-440.
45. Zhang W, Chen X, Kato Y, Evans PM, Yuan S, Yang J et al. (2006). Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 26: 2055-2064.